Rosa‐Helena Bustos

1.3k total citations
49 papers, 900 citations indexed

About

Rosa‐Helena Bustos is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rosa‐Helena Bustos has authored 49 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 9 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Rosa‐Helena Bustos's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Rosa‐Helena Bustos is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Rosa‐Helena Bustos collaborates with scholars based in Colombia, Chile and Spain. Rosa‐Helena Bustos's co-authors include Carlos Peña-Guzmán, Karen L. Mora, Manuel J. Rodríguez, Ellie Anne López-Barrera, Julio César García Casallas, Daniel G. Pinacho, Ghulam Md Ashraf, George E. Barreto, Marisa Cañadas‐Garre and Luis E. Fernández and has published in prestigious journals such as Analytical Chemistry, International Journal of Molecular Sciences and Journal of Environmental Management.

In The Last Decade

Rosa‐Helena Bustos

46 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa‐Helena Bustos Colombia 15 210 165 149 130 102 49 900
Rui Weng China 22 351 1.7× 165 1.0× 143 1.0× 36 0.3× 33 0.3× 77 1.2k
Eliza Blicharska Poland 15 167 0.8× 132 0.8× 119 0.8× 62 0.5× 22 0.2× 56 1.2k
Chenxiao Liu China 14 178 0.8× 62 0.4× 87 0.6× 68 0.5× 143 1.4× 51 1.0k
Baobo Zou China 21 382 1.8× 355 2.2× 70 0.5× 41 0.3× 59 0.6× 35 1.6k
Reena V. Saini India 19 293 1.4× 173 1.0× 30 0.2× 62 0.5× 133 1.3× 43 1.7k
Sobia Noreen Pakistan 21 159 0.8× 218 1.3× 123 0.8× 30 0.2× 44 0.4× 68 1.5k
Zhongwei Yang China 22 575 2.7× 130 0.8× 97 0.7× 56 0.4× 17 0.2× 54 1.4k
Kang Li China 17 260 1.2× 91 0.6× 130 0.9× 26 0.2× 45 0.4× 48 1.0k

Countries citing papers authored by Rosa‐Helena Bustos

Since Specialization
Citations

This map shows the geographic impact of Rosa‐Helena Bustos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa‐Helena Bustos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa‐Helena Bustos more than expected).

Fields of papers citing papers by Rosa‐Helena Bustos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa‐Helena Bustos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa‐Helena Bustos. The network helps show where Rosa‐Helena Bustos may publish in the future.

Co-authorship network of co-authors of Rosa‐Helena Bustos

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa‐Helena Bustos. A scholar is included among the top collaborators of Rosa‐Helena Bustos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa‐Helena Bustos. Rosa‐Helena Bustos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mena, M., et al.. (2025). Vancomycin Population Pharmacokinetic Models in Non- Critically Ill Adults Patients: a scoping review. F1000Research. 11. 1513–1513. 1 indexed citations
2.
Bustos, Rosa‐Helena, et al.. (2024). Assessment of Medication Adherence Using Mobile Applications in Chronic Obstructive Pulmonary Disease: A Scoping Review. International Journal of Environmental Research and Public Health. 21(10). 1265–1265.
3.
Mena, M., et al.. (2024). Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder. Expert Review of Neurotherapeutics. 24(9). 837–848. 1 indexed citations
4.
Mena, M., Julio César García Casallas, & Rosa‐Helena Bustos. (2023). Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients. Antibiotics. 12(2). 301–301. 2 indexed citations
5.
Díaz, Luis E., et al.. (2022). A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation. Plants. 11(10). 1357–1357. 12 indexed citations
6.
Casallas, Julio César García, et al.. (2021). Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes. Pharmaceutics. 13(10). 1630–1630. 3 indexed citations
7.
Fuentes, Yuli V., et al.. (2021). Administration and Therapeutic Drug Monitoring of β-lactams and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study. Pharmaceutics. 13(10). 1577–1577. 4 indexed citations
8.
León, Marta, et al.. (2021). Clinical Evidence of Magistral Preparations Based on Medicinal Cannabis. Pharmaceuticals. 14(2). 78–78. 9 indexed citations
9.
Bustos, Rosa‐Helena, et al.. (2020). Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview. Pharmaceuticals. 13(3). 42–42. 11 indexed citations
10.
Bustos, Rosa‐Helena, et al.. (2020). Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines. 8(9). 303–303. 2 indexed citations
11.
Peña-Guzmán, Carlos, et al.. (2019). Emerging pollutants in the urban water cycle in Latin America: A review of the current literature. Journal of Environmental Management. 237. 408–423. 278 indexed citations
12.
Bustos, Rosa‐Helena, et al.. (2019). Pseudomonas aeruginosa Coharboring BlaKPC-2 and BlaVIM-2 Carbapenemase Genes. Antibiotics. 8(3). 98–98. 17 indexed citations
13.
Bustos, Rosa‐Helena, et al.. (2019). An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection. Antibiotics. 8(3). 100–100. 28 indexed citations
14.
Bustos, Rosa‐Helena, et al.. (2018). Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor. Sensors. 18(3). 691–691. 12 indexed citations
15.
Casallas, Julio César García & Rosa‐Helena Bustos. (2018). The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives. Brain Sciences. 8(12). 222–222. 29 indexed citations
16.
Bustos, Rosa‐Helena, et al.. (2018). New ABCC2 rs3740066 and rs2273697 Polymorphisms Identified in a Healthy Colombian Cohort. Pharmaceutics. 10(3). 93–93. 3 indexed citations
17.
Bustos, Rosa‐Helena, et al.. (2018). Diabetes-Related Neurological Implications and Pharmacogenomics. Current Pharmaceutical Design. 24(15). 1695–1710. 42 indexed citations
18.
Bustos, Rosa‐Helena, Alejandra Tordecilla‐Sanders, Jorge Enrique Correa‐Bautista, et al.. (2018). Acute Effects of High Intensity, Resistance, or Combined Protocol on the Increase of Level of Neurotrophic Factors in Physically Inactive Overweight Adults: The BrainFit Study. Frontiers in Physiology. 9. 741–741. 49 indexed citations
19.
Bustos, Rosa‐Helena, et al.. (2017). Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach. Current Pharmaceutical Design. 24(1). 22–45. 32 indexed citations
20.
Reid, M. S., María Teresa Ulloa, Rosa‐Helena Bustos, et al.. (1995). Development of Highly Specific Monoclonal Antibodies for the Diagnosis of Vibrio cholerae 01. Hybridoma. 14(3). 271–278. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rui Weng Breakdown of academic impact, for papers by Eliza Blicharska Breakdown of academic impact, for papers by Chenxiao Liu Breakdown of academic impact, for papers by Baobo Zou Breakdown of academic impact, for papers by Reena V. Saini Breakdown of academic impact, for papers by Sobia Noreen Breakdown of academic impact, for papers by Zhongwei Yang Breakdown of academic impact, for papers by Kang Li
Rankless by CCL
2026